Cardiac function depends on the highly regulated and co-ordinate activity of a large ensemble of potassium channels that control myocyte repolarization. While voltage-gated K + channels have been well characterized in the heart, much less is known about regulation and/or targeting of two-pore K + channel (K 2P ) family members, despite their potential importance in modulation of heart function.
Introduction
Normal cardiac cell excitability depends on the proper membrane targeting and activity of a large number of potassium channels that contribute to all phases of the action potential (AP).
1 Dozens of distinct K + channels have been identified in mammalian heart, many of which are common targets for drugs, hormones, and other factors that regulate membrane excitability and, in turn, heart function. Importantly, defects in cardiac potassium channels have been extensively linked with congenital and acquired forms of cardiac arrhythmia. 1 -3 While voltagegated K + channels have been widely studied and well characterized in the field of cardiac electrophysiology, recent studies have identified new classes of channels that, while not strongly gated by voltage, are highly regulated by a myriad of physiological and pathophysiological agonists. 4 One such channel superfamily are the two-pore K + channels (K 2P ), encoded by at least 15 different genes with six subfamilies. K 2P family members, in general, show weak voltage dependence and low sensitivity to common K + channel inhibitors, making them ideal candidates for background (or leak) K + conductance in a variety of cells. 4, 5 While not well studied in the heart, TREK-1 (encoded by KCNK2) has been well characterized in the nervous system and is believed to mediate cellular processes involved in neuroprotection, pain, and depression in response to a variety of chemical and physical stimuli. 6 -9 Additional roles for TREK-1 have been identified in endothelial vasodilation and gestational myometrial relaxation. 10, 11 However, very little is known about the role of TREK-1 in the heart, let alone the molecular pathways responsible for membrane targeting of this uniquely regulated channel.
Here, we report that b IV -spectrin, an actin-associated protein, is required for the membrane targeting and activity of TREK-1 in the heart. Moreover, this targeting is highly specific for TREK-1 over other K + channels including the homologous K 2P family member TREK-2.
We demonstrate that b IV -spectrin and TREK-1 are co-localized at the myocyte intercalated disc and associate in the heart. Myocytes from b IVspectrin mutant mice (qv 4J ) lacking spectrin -TREK-1 interaction display defects in TREK-1 membrane targeting and activity. Consistent with a physiological role for the spectrin-based complex, qv 4J mice display defects in cardiac repolarization and arrhythmia. Finally, our data suggest broader roles for b IV -spectrin in common forms of cardiovascular disease as b IV -spectrin levels are altered in human heart failure. In summary, our data provide the first in vivo data on molecular pathways responsible for membrane targeting of TREK-1 channels in the heart and establish a new role for b IV -spectrin at the myocyte intercalated disc.
Methods

Animals
qv 4J mice (express a mutant b IV -spectrin allele with a pre-mature stop codon prior to the ankyrin-binding site) 12 and wild-type (WT) littermates were obtained from Jackson Laboratories. All experiments were performed in 2-month-old male mice . Animals were euthanized using CO 2 and cervical dislocation followed by collection of tissue or cell isolation. Studies were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health following protocols that were reviewed and approved by the Institutional Animal Care and Use Committee at The Ohio State University.
Molecular biology
cDNA for b IV -spectrin and TREK-1 (C-terminal cytoplasmic region: 305-422) fusion proteins was cloned from human heart cDNA library, as described previously. 13 Constructs for in vitro translation and fusion protein expression were generated by engineering cDNAs in frame into pcDNA3.1 + (Invitrogen) and pGEX6P1 (GE Healthcare). StepOnePlus Real-Time PCR System (Life Technologies). PCR data were analysed using the relative standard curve method and the 2 delta Ct method was used to calculate fold changes in relative gene expression. PCR products were confirmed by the melt-curve analysis, amplicon length, and DNA sequencing. Actb (beta-actin) levels were used as a normalization control.
Quantitative real-time PCR
Biochemistry
Equal quantities of ventricular lysates (determined by standard BCA protocols) were analysed by SDS-PAGE and immunoblot. Equal protein loading was verified through Coomassie and Ponceau stains of gels and blots. Additionally, small differences in protein loading were corrected using normalization to levels of actin or GAPDH. Adult heart immunoprecipitations were performed, as described previously. 13 The following antibodies were used for immunoblotting, immunoprecipitation, or immunostaining: ankyrin-G, 14 
Electrophysiology
Ventricular myocytes were isolated from Langendorff-perfused adult mouse hearts, as described previously. 25 Current recordings were performed on freshly isolated (,1 h in culture) myocytes by a conventional whole-cell patch-clamp technique with an Axon 200B patch-clamp amplifier controlled by a personal computer using a Digidata 1320A acquisition board and the pClamp 10.0 software (Axon Instruments). Standard protocols were used to measure K + and Ca 2+ . 13 TREK-1 current (arachidonic acid sensitive current) was measured using a slow (6 mV/s) voltage ramp from 290 to +30 mV, as described previsouly. 26 Briefly, bath solution contained (in mM): 150 NaCl, 2.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 8 glucose, and 10 HEPES (pH 7.4). Pipette solution contained (in mM): 120 K-aspartate, 20 KCl, 10 EGTA, 1.0 MgCl 2 , 2.0 Na 2 ATP, 0.1 mM Na 4 GTP, 20 mM HEPES; 1 mM glibenclamide and 100 mM CdCl 2 were added to block ATP-sensitive K + channels and voltage-gated Ca 2+ channels, and 10 mM arachidonic acid was used to determine TREK-1 as difference current. All current recording experiments were conducted at room temperature (21 -238C). Recording pipettes, fabricated from borosilicate glass, had resistance of 2-4 MV, when filled with recording solution. All solutions were adjusted to 275-295 mOsm.
AP measurements
APs were recorded using the perforated (amphotericin B) patch-clamp technique at 368C in Tyrode's solution (bath). The pipette contained (in mM): 130 potassium aspartate, 10 NaCl, 10 HEPES, 0.04 CaCl 2 , 2.0 MgATP, 7.0 phosphocreatine, 0.1 NaGTP, and 240 mg/mL amphotericin B, with the pH adjusted to 7.2 with KOH. APs were evoked by brief current pulses 1.5 -4 pA, 0.5 -1 ms. AP duration (APD) was assessed as the time from the AP upstroke to 90% repolarization to baseline (APD 90 ).
Ca 21 handling
Isolated ventricular myocytes were loaded with a Ca 2+ -dependent dye, fluo-4 AM (10 mM), for 30 min at room temperature. Myocytes were electrically field stimulated at 0. 
Adult mouse ventricular myocyte culture
Freshly isolated adult mouse ventricular myocytes were dispersed in plating media (MEM, 100 U/L penicillin -streptomycin, 2 mM L-glutamine, 20 mM 2,3-butanedione monoxime, 5% foetal calf serum), seeded on laminin-coated 6-well plates, and incubated for 1 h at 378C in 2% CO 2 . Cells were washed three times and the plating media was replaced by culture media (MEM, 100 U/mL penicillinstreptomycin, 2 mM L-glutamine, 0.1 mg/mL bovine serum albumin, 10 mM 2,3-butanedione monoxime, 10 mg/mL insulin, 5.5 mg/mL transferrin, 5 ng/mL selenium, insulin-transferrin-sodium selenite media supplement). Acute TREK-1 knock-down was achieved by adding shRNA lentiviral particles (Santa Cruz, 5 × 10 4 MOI) to each well and incubating for 0, 12, or 24 h. After incubation, cells were rinsed three times with PBS, and fixed with 95% ethanol and 5% formic acid.
Telemetry
Implantation of radiotelemeters (DSI, St Paul, MN, USA) was performed in anaesthetized (1-4% isoflurane by inhalation) 2-month-old male mice. Following recovery (5 days), ECG recordings of unanaesthetized mice were obtained at baseline and following epinephrine injection. For baseline heart rate analysis, continuous ECG data were collected from both WT and qv 4J animals for 30 min on three separate days and analysed according to established protocol. 28 For stress tests, mice were injected with epinephrine (2 mg/kg) followed by 30 min of recording. Arrhythmia events were defined as having an R-R interval longer than 1.5 times the average R-R interval. Age and sex were the only identifying information acquired from tissue providers and the Iowa Human Subjects Committee deemed that informed consent was not required. The investigation conforms with the principles outlined in the Declaration of Helsinki.
Human tissue samples
Statistics
P-values were determined for single comparisons using unpaired Student's t-test (two-tailed). A P value of ,0.05 was considered statistically significant. Values are expressed as means + SE.
Results
b IV -Spectrin regulates cardiac repolarization
Previous studies have shown that b IV -spectrin interacts with the adapter protein ankyrin-G to organize functional ion channel macromolecular complexes in a variety of cells. 13 -15,29,30 Based on these findings, we hypothesized that b IV -spectrin interaction with ankyrin-G is essential for normal cardiomyocyte membrane excitability. To test this hypothesis, we utilized a mutant b IV -spectrin mouse model harbouring a premature stop codon prior to the ankyrin-binding site (qv 4J mouse, Figure 1 ). 12 Importantly, pull-down experiments reveal the association of ankyrin-G with WT but not qv 4J -b IV -spectrin-GST fusion proteins incubated with detergent-soluble mouse heart lysates ( Figure 1B) . Telemetry experiments in unanaesthetized mice revealed a small but significant increase in the QT interval in qv 4J animals, without any difference in baseline heart rate (R -R interval) or P -R interval ( Figure 1) . Interestingly, epinephrine challenge elicited a pronounced increase in heart rate variability and episodes of sinus node pause in qv 4J but not WT mice ( Figure 1) . Consistent with our ECG findings, qv 4J ventricular myocytes displayed an increase in APD without any difference in AP amplitude, dV/dt max , or resting membrane potential ( Figure 2 ). Together these data support a requirement of b IV -spectrin for normal cardiac repolarization and heart function.
b IV -Spectrin is essential for normal TREK-1 function in ventricular cardiomyocytes
The increase in APD and QT interval in qv 4J mice/myocytes led us to test whether loss of functional b IV -spectrin disrupts the membrane expression/activity of ion channels that control repolarization. We first measured protein levels by immunoblot, membrane expression, and activity of the inward rectifier K + current I K1 (K ir 2.1) and transient
3), two of the dominant repolarizing currents in the mouse. However, no differences were found in the expression or localization of these K + channels in qv 4J heart lysates compared with WT ( Figure 3) . Furthermore, no difference was observed in I K1 (28.2 + 0.33 vs. 27.9 + 0.38 pA/pF at 2100 mV in WT and qv 4J , respectively; n ¼ 17, P ¼ NS) or I to,fast (17.7 + 1.97 vs. 17.04 + 3.03 pA/pF, n ¼ 17, P ¼ NS) currents in WT and qv 4J myocytes (representative current traces in Supplementary material online, Figure S1 ). We also did not observe any difference in the expression or localization of K v 2.1, K v 1.5, or K v b1.2 (constituents of I K,slow , Supplementary material online, Figure S2 ). family members TASK-1 and the highly homologous TREK-2 were co-expressed with b IV -spectrin at the myocyte intercalated disc using affinity purified and validated polyclonal antibodies 20 -22 (TREK-1 antibody validation, including blocking peptide and shRNA knock-down experiments, is provided in Supplementary material online, Figures S5-7) .
While TREK-1, TREK-2, and TASK-1 were all found at the intercalated disc in WT myocytes, we observed a striking redistribution of TREK-1 in qv 4J myocytes with increased cytosolic localization of the protein (Figure 4 ). Detailed analysis of confocal Z-stack images demonstrates a prominent intracellular population of TREK-1 in qv 4J but not WT ventricular myocytes (see Supplementary material online, Figure S8 ). This pattern was apparent in .50% of imaged qv 4J cells but not in WT cells (100 total cells examined from five different preparations/genotype; independent, representative WT, and qv 4J myocytes shown in Figure 4 , and Supplementary material online, Figures S6 and 8) . These data indicate that b IV -spectrin is involved in normal membrane expression of TREK-1 in mouse ventricular myocytes. Importantly, RT-PCR and immunoblot experiments demonstrate the expression of TREK-1 in b IV -Spectrin regulates TREK-1 in the heart mouse and human heart (see Supplementary material online, Figure S9 ). Quantitative RT-PCR confirms a significant expression of Kcnk2 in atria, left ventricle, and right ventricle of mouse heart albeit at lower levels than Kcnh2 (see Supplementary material online, Figure S9 ).
To determine whether TREK-1 activity was altered in parallel with loss of membrane expression in qv 4J , we measured arachidonic acid-sensitive current, I K,AA , in WT and qv 4J ventricular myocytes. 26 Consistent with our biochemical and immunostaining data, we found a significant decrease in TREK-1 activity (measured as arachidonic acid-sensitive current, I K,AA ) 26 in qv 4J ventricular myocytes compared with WT ( Figure 5A and B) . Specifically, we observed a 66% decrease in peak arachidonic acid-sensitive current induced by a voltage ramp to +30 mV.
b IV -Spectrin and TREK-1 associate in the heart
Based on our functional data linking b IV -spectrin and TREK-1, we tested whether the two proteins were associated in the heart. Co-immunoprecipitation experiments revealed that TREK-1 resides in a complex with b IV -spectrin in WT but not qv 4J detergent-soluble heart lysates ( Figure 5C ), consistent with imaging and electrophysiology experiments. We performed pull-down experiments using a GST-b IVspectrin fusion protein containing all repeats absent from qv 4J mouse
[spectrin repeats 10 -17 (b IV (10 -17))] or a truncated fusion protein lacking the ankyrin-G-binding motif in repeat 15 [b IV (10) (11) (12) (13) (14) to determine the structural requirements for spectrin-dependent targeting of TREK-1 in the heart. While ankyrin-G was found to associate only with spectrin repeats 10-17 (consistent with location of the ankyrin-G-binding motif in repeat 15), TREK-1 bound to both fusion proteins ( Figure 5E ), suggesting that TREK-1 interaction with b IV -spectrin occurs independently of ankyrin-G via a motif in repeats 10 -14. Together these data indicate that TREK-1 resides in a complex with b IV -spectrin in the heart, b IV -spectrin is essential for normal TREK-1 membrane localization and function, and that this interaction does not require ankyrin-G.
Remodelling of b IV -spectrin in human heart failure
Heart failure (HF) is characterized by dramatic structural and electrical remodelling changes that promote mechanical dysfunction and create a substrate for life-threatening arrhythmias. We have previously reported defects in both ankyrin-and spectrin-based pathways in animal models of cardiovascular disease and in human HF and arrhythmias. 14,33 -38 We hypothesized that defects in b IV -spectrin may contribute to electrical remodelling associated with HF. As a first step in determining a broader role for b IV -spectrin in disease, we evaluated levels of b IV -spectrin in left ventricular samples from human patients with non-ischaemic HF ( Figure 6 ). Interestingly, we observed a significant decrease in b IVspectrin expression in HF samples compared with normal controls (Figure 6 ), suggesting that defects in spectrin and associated proteins may contribute to dysfunction in human disease.
Discussion
Cardiac function depends on highly evolved membrane-associated complexes composed of ion channels, receptors, signalling molecules, adapter, and cytoskeletal proteins that maintain tight control over cardiomyocyte activity at baseline and in response to stress. While functions of these membrane-associated platforms are well defined in the heart and other excitable cells, the mechanisms underlying their biogenesis and maintenance are not well understood, particularly in vivo. b IVspectrin has been identified to have important roles in organizing ion channel macromolecular complexes at select membrane domains (nodes of Ranvier, axon initial segment, cardiomyocyte intercalated disc) in neurons and myocytes. 13, 15, 30, 33, 39, 40 Importantly, defects in spectrin family members and associated proteins are linked to human disease, including hereditary anaemia, epilepsy, cardiac arrhythmia, and myopathy. 41 Our studies identify a novel b IV -spectrin-based complex involving the mechano-sensitive TREK-1 in ventricular cardiomyocytes. Given the expression of complex constituents in other tissues (especially brain), we anticipate broader implications for these findings outside of the heart. Likewise, given our previous findings that b IVspectrin targets CaMKIId to the intercalated disc, 13, 33 we anticipate that TREK-1 likely interacts with a large number of regulatory, adapter, and cytoskeletal proteins in the heart (e.g. CaMKII, popeye domain containing proteins). 42 It will be important for future studies to elucidate the precise relationship/function of b IV -spectrin/ankyrin-G and other TREK-1-associated proteins at the intercalated disc. Previous studies have identified bidirectional regulation between TREK-1 and the actin cytoskeleton. 43 Our findings demonstrate that b IV -Spectrin regulates TREK-1 in the heart TREK-1 belongs to a spectrin-based macromolecular complex at the cardiomyocyte intercalated disc and suggest that b IV -spectrin might serve as the previously unknown link between TREK-1 and the actin cytoskeleton. Furthermore, we find that defects in TREK-1 membrane expression alter AP repolarization at baseline. An unexpected finding of our study, based on the previously identified link between b IVspectrin, ankyrin-G, and voltage-gated Na + channels, 13 -15,29,30 is the dramatic effect of b IV -spectrin dysfunction on AP repolarization but not depolarization, which motivated the focus of this study on repolarizing K + channels. It will be important going forward to also address the potential role of b IV -spectrin in targeting ion channels important for myocyte depolarization (e.g. voltage-gated Na + channels). Finally, we present data that b IV -spectrin levels are altered in human heart failure. Based on our collective findings, we predict that spectrin may contribute to mechano-transduction in mammalian heart by transducing biomechanical stimuli at the membrane to the actin cytoskeleton, and eventually to the nucleus. Moreover, given the diversity of b IV -spectrin-associated proteins (actin, a-spectrin, ankyrin-G, Na v 1.5, TREK-1), we speculate that loss of b IV -spectrin plays a critical role in both electrical and structural remodelling observed in HF leading to changes in cytoskeletal and key membrane current (e.g. I Na, TREK-1) properties. 
Limitations
It is important to note that while our data establish a new role for b IVspectrin in controlling TREK-1 membrane expression, they do not conclusively define the role for TREK-1 in regulating cell excitability. Likewise, these studies do not identify TREK-1 as the sole source of repolarization defects in the qv 4J myocyte. Indeed, further study of these mice will be critical for identifying the likely complex molecular phenotype of these animals. Furthermore, the precise structural requirements for a TREK-1-b IV -spectrin interaction remain to be defined. Future studies (e.g. using a TREK-1 knockout mouse) will address these and other important unanswered questions regarding the nature/function of this novel spectrin-based complex at the intercalated disc. For example, does b IV -spectrin play a broader role for control of TREK-1 activity by jointly targeting accessory/regulatory proteins (e.g. CaMKII)? Does b IV -spectrin control membrane targeting of additional ion channels (e.g. Na v 1.5) in concert with TREK-1? Is TREK-1 activity altered in failing human heart consistent with our report of decreased b IV -spectrin levels? Finally, and perhaps most importantly, can the unique regulatory profile of TREK-1 be exploited for therapeutic advantage in the setting of cardiovascular disease?
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